LC-ESI-MS/MS method for the accurate quantification of eight nitrosamines in pharmaceutical products
European Journal of Mass Spectrometry · 2025-02 · 31 (1-2) · 51-62
DOI: 10.1177/14690667251328823 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Mass Spectrometry, online erschienen am 21.03.2025. Verfasst von Ibrahim Danis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical Chemistry, Faculty of Pharmacy; Drug Research Center; Institute of Health Science, Istanbul University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Nitrosamines, Spectrometry, Mass, Electrospray Ionization. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
In 2018, the Food and Drug Administration and the European Medicines Agency identified nitrosamine impurities in certain drugs, prompting detailed investigations by international regulatory authorities. According to ICH M7 (R1) guidelines, nitrosamines are classified as Class 1 substances, the most hazardous category, based on their carcinogenic and mutagenic properties. They are also recognized as probable human carcinogens by the International Agency for Research on Cancer. Since nitrosamine-induced DNA damage poses significant health risks, identifying potential nitrosamines in pharmaceutical products is crucial. In this study, a simple and efficient extraction method was designed to minimize matrix effects. These effects were evaluated using calibration curves prepared for each drug product in their respective matrices. The developed method was performed using an Agilent 1260 series HPLC system and an Agilent 6460 triple quadrupole tandem mass spectrometer. An Inertsil ODS-3 C18 (5 µm, 4.6 × 150 mm) column was employed for chromatographic separation. A triple quadrupole mass detector with electrospray ionization was used for detection, and multiple reaction monitoring was employed for quantification. The correlation coefficients (r²) were at least 0.999 for all eight nitrosamines. Limit of detection and limit of quantification values were determined as 0.05–0.8 ng/mL and 0.1–2.0 ng/mL, respectively. Validation results demonstrated satisfactory selectivity, accuracy, precision, and stability. The results demonstrated that the developed method is capable of reliably detecting potential nitrosamines present in pharmaceutical products at trace levels. This method contributes significantly to pharmaceutical safety and can serve as a valuable tool for future analyses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Analytical Chemistry, Faculty of Pharmacy; Drug Research Center; Institute of Health Science, Istanbul University, Istanbul, Turkey.
- Department of Analytical Chemistry, Faculty of Pharmacy; Drug Research Center, Istanbul University, Istanbul, Turkey.
ORCID-Profile: Ibrahim Danis
Zitieren
APA
Danis, I., & Unal, D. O. (2025). LC-ESI-MS/MS method for the accurate quantification of eight nitrosamines in pharmaceutical products. European Journal of Mass Spectrometry, 31(1-2), 51-62. https://doi.org/10.1177/14690667251328823
Vancouver
Danis I, Unal DO. LC-ESI-MS/MS method for the accurate quantification of eight nitrosamines in pharmaceutical products. European Journal of Mass Spectrometry. 2025;31(1-2):51-62. doi:10.1177/14690667251328823
BibTeX
@article{Danis2025,
author = {Danis, Ibrahim and Unal, Durisehvar Ozer},
title = {LC-ESI-MS/MS method for the accurate quantification of eight nitrosamines in pharmaceutical products},
journal = {European Journal of Mass Spectrometry},
year = {2025},
volume = {31},
number = {1-2},
pages = {51--62},
doi = {10.1177/14690667251328823}
}
EUVIMED